Left Menu
Development News Edition

Nicaragua in talks to acquire Russia's Sputnik V COVID vaccine, says PAHO

Nicaragua is in talks with Russia's Gamaleya Institute to acquire the Sputnik V COVID-19 vaccine, the Pan American Health Organization (PAHO) said on Wednesday. The poor Central American nation is among the Latin American countries with least vaccines pre-ordered to tackle the coronavirus pandemic. "Nicaragua is negotiating with the Russian laboratory Nikolay Gamaleya to acquire the...Sputnik V vaccine," said Jarbas Barbosa, PAHO's assistant director, during an online news conference.

Reuters | Managua | Updated: 14-01-2021 03:39 IST | Created: 14-01-2021 03:39 IST
Nicaragua in talks to acquire Russia's Sputnik V COVID vaccine, says PAHO

Nicaragua is in talks with Russia's Gamaleya Institute to acquire the Sputnik V COVID-19 vaccine, the Pan American Health Organization (PAHO) said on Wednesday. The poor Central American nation is among the Latin American countries with least vaccines pre-ordered to tackle the coronavirus pandemic.

"Nicaragua is negotiating with the Russian laboratory Nikolay Gamaleya to acquire the...Sputnik V vaccine," said Jarbas Barbosa, PAHO's assistant director, during an online news conference. PAHO is the regional office of the World Health Organization PAHO said that Nicaragua will also begin receiving vaccines through the COVAX facility coordinated by the World Health Organization to support lower-income countries as of March.

Managua's Sputnik V talks adds to a flurry of interest from left-wing Latin American governments, with Mexico and Bolivia joining early-adopter Argentina in trying to lock down supplies of the Russian vaccine. Mexican health authorities expect to make a decision this week on whether to authorize Sputnik V after getting access to clinical data, and are considering buying 24 million doses.

Nicaragua's Vice President Rosario Murillo confirmed later on Wednesday that Nicaragua had begun to make arrangements to buy vaccines, but did not specify which ones. "We know that there are four vaccines with greater than 90% efficacy ... we are fully in the process of signing purchase agreements as soon as possible," said Murillo.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

With 'Made in India' solutions, nation controlled COVID-19 spread, improved medical infra: PM Modi

Prime Minister Narendra Modi on Friday said that the country was able to contain COVID-19 spread with Made in India solutions and also improved the medical infrastructure. Addressing the 18th Convocation of Tezpur University, PM Modi said t...

Britain's John Lewis lifts profit guidance after strong Christmas

Britains John Lewis Partnership lifted its annual profit forecast after better than expected trading during the Christmas period. The department stores and Waitrose supermarket chain owner said it now expected its profits to be ahead of gui...

Adani Total Gas, Torrent Gas acquire 5 pc stake each in IGX

Adani Total Gas and Torrent Gas have become the first strategic investors in IGX Indian Gas Exchange by acquiring five per cent stake each, according to the Indian Energy Exchange IEX.The IGX is an arm of IEX and first authorised gas exchan...

US STOCKS-Wall Street pauses at record highs after Biden bounce

Wall Streets main indexes hovered near record highs on Thursday as investors counted on more pandemic relief and speedy vaccine rollouts under the Biden administration to support the economy after data showed a weakening labor market recove...

Give Feedback